Group One Trading, L.P. Titan Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.45 - $0.66 $45 - $66	-100 Reduced 30.3%	230 $0
Q1 2023 May 12, 2023	BUY	$0.73 - $1.05 $19 - $28	27 Added 8.91%	330 $0
Q4 2022 Feb 09, 2023	BUY	$0.77 - $22.8 $233 - $6,908	303 New	303 $0
Q2 2022 Aug 11, 2022	BUY	$0.38 - $0.94 $228 - $564	600 Added 1.02%	59,504 $33,000
Q1 2022 May 12, 2022	BUY	$0.89 - $1.26 $12,590 - $17,825	14,147 Added 31.61%	58,904 $56,000
Q4 2021 Feb 11, 2022	BUY	$1.02 - $1.93 $30,356 - $57,438	29,761 Added 198.46%	44,757 $46,000
Q3 2021 Nov 12, 2021	SELL	$1.87 - $2.57 $27,156 - $37,321	-14,522 Reduced 49.2%	14,996 $28,000
Q2 2021 Aug 10, 2021	SELL	$2.24 - $2.9 $97,652 - $126,425	-43,595 Reduced 59.63%	29,518 $77,000
Q1 2021 May 12, 2021	BUY	$2.66 - $4.23 $192,336 - $305,858	72,307 Added 8971.09%	73,113 $218,000
Q4 2020 Feb 10, 2021	BUY	$3.0 - $6.0 $2,418 - $4,836	806 New	806 $3,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $52.8M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.